주식/증권
📈 긍정적
10x Genomics Q2 Earnings & Revenues Beat Estimates, Gross Margin Up
요약
TXG beats Q2 earnings and revenue estimates, expands gross margin and raises its 2026 revenue outlook despite a year-over-year sales decline.